Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clive Rosendorff

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Neurology|August 17, 2012
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive agingJeremy M Silverman, James Schmeidler, Michal S Beeri, et al.
Circulation|May 16, 2007
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and PreventionClive Rosendorff, Henry R Black, Christopher P Cannon, et al.
Neurology|February 28, 2016
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adultsManjula Kurella Tamura, Nicholas M Pajewski, R Nick Bryan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
JACC. Heart Failure|November 30, 2019
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of DiureticsBharathi Upadhya, Laura C Lovato, Michael Rocco, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2018
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)Brian P Shapiro, Walter T Ambrosius, Joseph L Blackshear, et al.
Kidney International. Supplement|October 16, 2004
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuriaNagesh S Anavekar, Daniel J Gans, Tomas Berl, et al.
Circulation|October 13, 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure ControlSrinivasan Beddhu, Glenn M Chertow, Alfred K Cheung, et al.
Circulation|April 2, 2015
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of HypertensionClive Rosendorff, Daniel T Lackland, Matthew Allison, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Neurology|August 17, 2012
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive agingJeremy M Silverman, James Schmeidler, Michal S Beeri, et al.
Circulation|May 16, 2007
Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and PreventionClive Rosendorff, Henry R Black, Christopher P Cannon, et al.
Neurology|February 28, 2016
Chronic kidney disease, cerebral blood flow, and white matter volume in hypertensive adultsManjula Kurella Tamura, Nicholas M Pajewski, R Nick Bryan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 5, 2008
Progression of kidney disease in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin versus usual care: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Mahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
Clinical Nephrology|July 3, 2013
Pravastatin and cardiovascular outcomes stratified by baseline eGFR in the lipid- lowering component of ALLHATMahboob Rahman, Charles Baimbridge, Barry R Davis, et al.
JACC. Heart Failure|November 30, 2019
Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of DiureticsBharathi Upadhya, Laura C Lovato, Michael Rocco, et al.
Hypertension (Dallas, Tex. : 1979)|May 2, 2018
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial)Brian P Shapiro, Walter T Ambrosius, Joseph L Blackshear, et al.
Kidney International. Supplement|October 16, 2004
Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuriaNagesh S Anavekar, Daniel J Gans, Tomas Berl, et al.
Circulation|October 13, 2017
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure ControlSrinivasan Beddhu, Glenn M Chertow, Alfred K Cheung, et al.
Circulation|April 2, 2015
Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of HypertensionClive Rosendorff, Daniel T Lackland, Matthew Allison, et al.
Pageof 7